Journal article icon

Journal article

Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

Publication status:
Published

Actions

Authors


Journal:
DIABETOLOGIA More from this journal
Volume:
55
Pages:
S314-S315
Publication date:
2012-10-01
ISSN:
0012-186X


Pubs id:
pubs:448682
UUID:
uuid:013d460a-c7fc-4173-9310-aa8d15b37ab6
Local pid:
pubs:448682
Source identifiers:
448682
Deposit date:
2014-10-07
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP